Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cognitive impairment of Alzheimer disease.

Folstein MF, Whitehouse PJ.

Neurobehav Toxicol Teratol. 1983 Nov-Dec;5(6):631-4. Review.

PMID:
6366602
2.

[Quantified neuropsychological study in senile dementia of Alzheimer's type].

Roudier M, Marcie P, Podrabinek N, Lamour Y, Davous P.

Encephale. 1989 Jul-Aug;15(4):397-403. French.

PMID:
2806182
3.

Mini-object test: a new brief clinical assessment for aphasia-apraxia-agnosia.

Still CN, Goldschmidt TJ, Mallin R.

South Med J. 1983 Jan;76(1):52-4.

PMID:
6823578
4.

Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population.

Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, Longley W, Sulway MR.

Arch Neurol. 1996 Oct;53(10):1056-61.

PMID:
8859068
5.

Neuropsychological predictors of dependency in patients with Alzheimer disease.

Sarazin M, Stern Y, Berr C, Riba A, Albert M, Brandt J, Dubois B.

Neurology. 2005 Mar 22;64(6):1027-31.

PMID:
15781821
6.

Awareness of cognitive deficits and anosognosia in probable Alzheimer's disease.

Lopez OL, Becker JT, Somsak D, Dew MA, DeKosky ST.

Eur Neurol. 1994;34(5):277-82.

PMID:
7995303
7.

[Awareness of deficits and anosognosia in Alzheimer's disease].

Antoine C, Antoine P, Guermonprez P, Frigard B.

Encephale. 2004 Nov-Dec;30(6):570-7. Review. French.

PMID:
15738860
8.

Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.

Lam LC, Lui VW, Tam CW, Chiu HF.

Int J Geriatr Psychiatry. 2005 Sep;20(9):876-82.

PMID:
16116581
9.

Slowly progressive visual agnosia or apraxia without dementia.

De Renzi E.

Cortex. 1986 Mar;22(1):171-80.

PMID:
2423295
10.

Mild cognitive impairment: cognitive screening or neuropsychological assessment?

Diniz BS, Nunes PV, Yassuda MS, Pereira FS, Flaks MK, Viola LF, Radanovic M, Abreu ID, Borelli DT, Gattaz WF, Forlenza OV.

Rev Bras Psiquiatr. 2008 Dec;30(4):316-21.

11.

[Cognitive manifestations of Alzheimer's disease].

Ousset PJ.

Rev Prat. 1998 Nov 1;48(17):1891-7. French.

PMID:
9854391
12.

Development of aphasia, apraxia, and agnosia and decline in Alzheimer's disease.

Yesavage JA, Brooks JO 3rd, Taylor J, Tinklenberg J.

Am J Psychiatry. 1993 May;150(5):742-7.

PMID:
8480819
13.

The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.

Rozzini L, Vicini Chilovi B, Bertoletti E, Conti M, Delrio I, Trabucchi M, Padovani A.

J Geriatr Psychiatry Neurol. 2008 Dec;21(4):261-7. doi: 10.1177/0891988708324940.

PMID:
19017783
14.

CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.

van der Vlies AE, Verwey NA, Bouwman FH, Blankenstein MA, Klein M, Scheltens P, van der Flier WM.

Neurology. 2009 Mar 24;72(12):1056-61. doi: 10.1212/01.wnl.0000345014.48839.71.

PMID:
19307538
15.

[Neuropsychological impairment in the early Alzheimer's disease].

Traykov L, Rigaud AS, Cesaro P, Boller F.

Encephale. 2007 May-Jun;33(3 Pt 1):310-6. Review. French.

PMID:
17675928
16.
17.

Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.

Rozzini L, Chilovi BV, Conti M, Bertoletti E, Delrio I, Trabucchi M, Padovani A.

Int J Geriatr Psychiatry. 2007 Dec;22(12):1217-22.

PMID:
17562522
18.

Anosognosia in Alzheimer disease.

Kotler-Cope S, Camp CJ.

Alzheimer Dis Assoc Disord. 1995 Spring;9(1):52-6.

PMID:
7605623
19.
20.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. French.

PMID:
19081451

Supplemental Content

Support Center